Publish in this journal
Journal Information

Statistics

Original Article
LncRNA MALAT1 Promotes Lung Cancer Proliferation and Gefitinib Resistance by Acting as a miR-200a Sponge
LncRNA MALAT1 promueve la profileración de las células tumorales de pulmón y su resistencia a gefitinib actuando como esponja para miR-200a
Changjiang Fenga,, Yi Zhaob,, Yunjing Lia, Tong Zhanga, Yongfu Maa,
Corresponding author
mayongfu301@126.com

Corresponding author.
, Yang Liua,
Corresponding author
liuyang301hospital@126.com

Corresponding author.
a Department of Thoracic Surgery, PLA General Hospital, Beijing 100853, China
b Department of Thoracic Surgery, Integrated Hospital of Traditional Chinese Medicine, Southern Medical University, Guangzhou 510315, China
Read
4
Times
was read the article
0
Total PDF
4
Total HTML
0
Total EPUB
Share statistics
Article information
ISSN: 15792129
Original language: English
The statistics are updated each day
Year/Month Html Pdf Epub Total
2021 January 0 0 0 0
2020 December 0 0 0 0
2020 November 0 0 0 0
2020 October 0 0 0 0
2020 September 0 0 0 0
2020 August 0 0 0 0
2020 July 0 0 0 0
2020 June 0 0 0 0
2020 May 0 0 0 0
2020 April 1 0 0 1
2020 March 3 0 0 3
2020 February 0 0 0 0
2020 January 0 0 0 0
2019 December 0 0 0 0
Show all
Idiomas
Archivos de Bronconeumología (English Edition)

Subscribe to our newsletter

es en

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

es en
Política de cookies Cookies policy
Utilizamos cookies propias y de terceros para mejorar nuestros servicios y mostrarle publicidad relacionada con sus preferencias mediante el análisis de sus hábitos de navegación. Si continua navegando, consideramos que acepta su uso. Puede cambiar la configuración u obtener más información aquí. To improve our services and products, we use "cookies" (own or third parties authorized) to show advertising related to client preferences through the analyses of navigation customer behavior. Continuing navigation will be considered as acceptance of this use. You can change the settings or obtain more information by clicking here.